Search Results - "Fragio Gil, J"

PO.8.175 Antimalarial drugs and electrocardiographic alterations in patients with systemic lupus erythematosus by Riesco Barcena, C, Leal Rodríguez, S, Acosta de la Vega, ME, Grau García, E, Pávez Perales, C, Huaylla Quispe, AV, De la Rubia, M, Muñoz Martínez, P, Mas Sánchez, L, Martínez Cordellat, I, Nájera Herranz, C, Negueroles Albuixech, R, Ortiz-Sanjuán, F, Vicens Bernabéu, E, Cánovas Olmos, I, Fragio Gil, JJ, González Puig, L, Oller Rodríguez, J, Ivorra Cortés, J, Román Ivorra, JA

“…Background During the first months of the Sars-CoV-2 pandemic, antimalarial drugs were the central axis of the treatment of patients with acute respiratory…”
Get full text

PO.3.61 Renal involvement and cardiovascular risk in systemic lupus erythematosus patients by De La Rubia Navarro, M, Grau Garcia, E, Pavez Perales, C, Ivorra Cortes, JR, Gonzalez Puig, L, Negueroles Albuixech, R, Martinez Cordellat, I, Herranz Najera, C, Francisco Miguel, OS, Fragio Gil, J, Canovas Olmos, I, Vicens Bernabeu, E, Oller Rodriguez, JE, Leal Rodriguez, S, Riesco Barcena, C, Huaylla Quispe, AV, Mas Sanchez, L, Muñoz Martinez, P, Roman Ivorra, JA

“…BackgroundSystemic lupus erythematosus (SLE) is an autoimmune disease which generally affects young woman. Kidney affection appears in around 40% of patients…”
Get full text

PO.5.116 Lupus nephritis response in terms of kidney function, urine sediment and serological activity after belimumab treatment by De La Rubia Navarro, M, Grau Garcia, E, Pavez Perales, C, Leal Rodriguez, S, Riesco Barcena, C, Huaylla Quispe, AV, Ivorra Cortes, JR, Gonzalez Puig, L, Negueroles Albuixech, R, Martinez Cordellat, I, Najera Herranz, C, Fragio Gil, J, Gonzalez Mazario, R, Canovas Olmos, I, Vicens Bernabeu, E, Oller Rodriguez, J, Mas Sanchez, L, Muñoz Martinez, P, Roman Ivorra, JA

“…BackgroundSystemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease characterized by an immune dysregulation and autoantibodies production…”
Get full text